Myriad Genetics MYGN Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$399.9M-9.3% | -$365.9M+8.6% | -$400.5M-1.3% | -$395.2M-290% | -$101.4M+20.3% | ||
| $51.8M-3.5% | $53.7M-3.9% | $55.9M-5.1% | $58.9M-1.7% | $59.9M-2.1% | ||
| $32.2M-8.5% | $35.2M-18.7% | $43.3M-0.5% | $43.5M-8.0% | $47.3M-5.0% | ||
| $2.4M+33.3% | $1.8M— | —— | —— | —— | ||
| -$25.6M+6.6% | -$27.4M-0.4% | -$27.3M— | —— | —— | ||
| —— | —— | —— | —— | $100M-16.7% | ||
| —— | —— | —— | —— | $80M-33.1% | ||
| —— | —— | —— | —— | —— | ||
| $28.5M-33.6% | $42.9M— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Myriad Genetics generate?
- Myriad Genetics (MYGN) generated $2.4M in operating cash flow over the trailing twelve months.
- Where does Myriad Genetics's cash flow data come from?
- Every line is extracted from Myriad Genetics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
